Detalhe da pesquisa
1.
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Clin Cancer Res
; 30(9): 1739-1749, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456660
2.
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.
Nat Med
; 29(2): 458-466, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702949
3.
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250394
4.
Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas.
Clin Cancer Res
; 27(23): 6343-6353, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330715
5.
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.
Clin Cancer Res
; 27(20): 5586-5594, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926918
6.
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma.
Cancer Discov
; 11(10): 2488-2505, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926920
7.
Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition.
NPJ Precis Oncol
; 4: 21, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32802958
8.
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers.
Clin Cancer Res
; 26(8): 1877-1885, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941831
9.
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Nat Med
; 25(12): 1949, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745334
10.
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Cancer Discov
; 9(8): 1064-1079, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31109923
11.
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Nat Med
; 25(9): 1415-1421, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501609